{"id":4203,"count":2,"description":"<strong>Tuberculosis (TB)<\/strong> tov\u00e1bbra is az egyik legpuszt\u00edt\u00f3bb fert\u0151z\u0151 betegs\u00e9g a vil\u00e1gon \u2014 a WHO becsl\u00e9se szerint 2022-ben 10,6 milli\u00f3 ember betegedett meg TB-ben, \u00e9s 1,3 milli\u00f3an haltak bele, k\u00f6zt\u00fck 167 000 HIV-koinfekci\u00f3val. A betegs\u00e9get a <em>Mycobacterium tuberculosis<\/em>, bakt\u00e9rium okozza, amely lassan n\u00f6vekv\u0151, intracellul\u00e1ris baci, \u00e9s els\u0151sorban a t\u00fcd\u0151t \u00e9rinti, de szinte b\u00e1rmely szervrendszert megbeteg\u00edthet. <strong>A modern, r\u00f6vid ter\u00e1pi\u00e1s TB-kezel\u00e9s teljesen gy\u00f3gy\u00edt\u00f3 hat\u00e1s\u00fa \u2014 de csak akkor, ha helyesen alkalmazz\u00e1k<\/strong>: a megfelel\u0151 gy\u00f3gyszerkombin\u00e1ci\u00f3t, a megfelel\u0151 d\u00f3zisban, a teljes kezel\u00e9si id\u0151tartam alatt, szakorvosi fel\u00fcgyelet mellett. Ez az oldal felsorolja a MedsBase-n\u00e1l kaphat\u00f3 antituberkulotikumokat. <strong>Ez nem \u00f6nkezel\u00e9si \u00fatmutat\u00f3 akt\u00edv TB eset\u00e9n.<\/strong>\nThe 4-drug RIPE regimen\nThe WHO standard regimen for new, drug-susceptible pulmonary tuberculosis is six months in two phases:\n<strong>Intenz\u00edv f\u00e1zis \u2014 2 h\u00f3nap:<\/strong> Rifampicin + Isoniazid + Pyrazinamide + <strong>Ethambutol<\/strong> (RIPE), mind a n\u00e9gy gy\u00f3gyszer napi adagol\u00e1sa.<strong>Folytat\u00f3 f\u00e1zis \u2014 4 h\u00f3nap:<\/strong> Rifampicin + Isoniazid (RH), continued daily.\nLonger regimens (9&ndash;12 months) apply to TB meningitis, bone and joint TB, and disseminated disease. Treatment is supervised &mdash; <strong>k\u00f6zvetlen\u00fcl megfigyelt ter\u00e1pia (DOT)<\/strong> is recommended in most national programmes to ensure adherence and to prevent the emergence of multidrug-resistant TB (MDR-TB).\nWhy combination therapy is mandatory\nSingle-agent treatment of active TB inevitably selects for resistant organisms. The bacterial load in a cavitating pulmonary lesion is enormous (up to 109 bacilli) and naturally occurring resistance mutations exist at low frequency for every drug. Using one drug kills the susceptible majority and leaves the resistant minority to multiply &mdash; treatment failure with a now-untreatable strain. <strong>A kombin\u00e1lt ter\u00e1pia<\/strong> az\u00e9rt m\u0171k\u00f6dik, mert annak val\u00f3sz\u00edn\u0171s\u00e9ge, hogy egy organizmus egyszerre t\u00f6bb gy\u00f3gyszerre is rezisztens, elhanyagolhat\u00f3an kicsi. Ez\u00e9rt minden oldal ebben a kateg\u00f3ri\u00e1ban egy\u00e9rtelm\u0171 figyelmeztet\u00e9st tartalmaz, hogy egyetlen gy\u00f3gyszer v\u00e1s\u00e1rl\u00e1sa csak akkor megfelel\u0151 <strong>csak<\/strong> for ongoing supervised regimen continuation, latent TB infection (4-month rifampicin monotherapy), or specific non-TB indications such as leprosy, MAC, or meningococcal prophylaxis.\nMultidrug-resistant TB &mdash; a warning\nMDR-TB &mdash; resistance to at least rifampicin and isoniazid &mdash; affected an estimated 410,000 people worldwide in 2022. MDR-TB requires longer treatment (9&ndash;20 months) with second-line agents including <strong>fluorokinolonok<\/strong> (levofloxacin, moxifloxacin), <strong>linezolid<\/strong>, <strong>bedaquilin<\/strong>, \u00e9s <strong>klofazimin<\/strong>. MDR-TB is the predictable downstream result of partial, irregular, or single-agent treatment of drug-susceptible TB. Cure is possible but harder, more expensive, and more toxic than first-line therapy &mdash; the case for getting the initial regimen right and completing it.\nAnti-TB medications stocked at MedsBase\nThis category currently lists <strong>k\u00e9t az els\u0151 vonalbeli n\u00e9gy szerb\u0151l<\/strong>:\n<a href=\"https:\/\/medsbase.com\/hu\/r-cin\/\"><strong>R-Cin<\/strong><\/a> \u2014 <strong>rifampicin 300\/450\/600 mg<\/strong> (Cipla). A legfontosabb steriliz\u00e1l\u00f3 szer a TB-ter\u00e1pi\u00e1ban. Haszn\u00e1lj\u00e1k m\u00e9g 4 h\u00f3napos monoter\u00e1piak\u00e9nt lappang\u00f3 TB-fert\u0151z\u00e9s eset\u00e9n (4R s\u00e9ma), multibacillaris lepra kezel\u00e9s\u00e9ben, meningococcus-kontaktus profilaxisban, valamint s\u00falyos staphylococcusos csont-, \u00edz\u00fclet- vagy prot\u00e9zis-fert\u0151z\u00e9sekben. A rifampicin <strong>f\u0151 CYP3A4 \/ CYP2C9 \/ CYP2C19 induk\u00e1l\u00f3<\/strong> \u2014 cs\u00f6kkenti sz\u00e1mos egy\u00fctt adott gy\u00f3gyszer hat\u00e9konys\u00e1g\u00e1t, k\u00f6zt\u00fck a fogamz\u00e1sg\u00e1tl\u00f3 tablett\u00e1k\u00e9t, a warfarint, a DOAC-okat, a statinokat, a metadont, a transzplant\u00e1ci\u00f3s immunszuppressz\u00e1nsokat, az antiretrovir\u00e1lis szereket \u00e9s sok m\u00e1s\u00e9t. <strong>Mindig jelentsd be minden egyidej\u0171leg szedett gy\u00f3gyszert a kezel\u00e9s megkezd\u00e9se el\u0151tt.<\/strong> Az vizelet, izzads\u00e1g, k\u00f6nny \u00e9s ny\u00e1l narancss\u00e1rga-v\u00f6r\u00f6s sz\u00ednez\u0151d\u00e9s\u00e9t okozza (\u00e1rtalmatlan, de l\u00e1gy kontaktlencs\u00e9ket maradand\u00f3an befest).<a href=\"https:\/\/medsbase.com\/hu\/combutol\/\"><strong>Combutol<\/strong><\/a> \u2014 <strong>ethambutol HCl 200\/400\/800 mg<\/strong> (Lupin). Bakteriosztatikus szer, amelynek szerepe a rezisztencia kialakul\u00e1s\u00e1nak megakad\u00e1lyoz\u00e1sa a baktericid partnerszerekhez szemben. Alapvet\u0151 szerepe van m\u00e9g a Mycobacterium avium komplex (MAC) fert\u0151z\u00e9s kezel\u00e9s\u00e9ben HIV-ben. F\u0151 toxicit\u00e1sa <strong>a d\u00f3zisf\u00fcgg\u0151 optikus neuritis<\/strong>: l\u00e1t\u00f3\u00e9less\u00e9g cs\u00f6kken\u00e9se \u00e9s v\u00f6r\u00f6s-z\u00f6ld sz\u00ednl\u00e1t\u00e1si zavar, amely \u00e1ltal\u00e1ban reverzibilis, ha a gy\u00f3gyszert az els\u0151 t\u00fcnetn\u00e9l le\u00e1ll\u00edtj\u00e1k, de permanens k\u00e1rosod\u00e1st is okozhat, ha nem. <strong>Alapvizsg\u00e1lat szem\u00e9szeti szakorvossal \u00e9s havi l\u00e1t\u00e1svizsg\u00e1latok k\u00f6telez\u0151ek.<\/strong> Renal-dose adjustment is essential.\nThe other two first-line agents &mdash; <strong>izoniazid<\/strong> \u00e9s <strong>pirazinamid<\/strong> &mdash; are not currently stocked at MedsBase. Patients on a full RIPE regimen will need to source these from another supplier, a hospital pharmacy, or their national TB programme. National TB programmes in most countries provide first-line TB drugs free of charge.\nMandatory monitoring during TB therapy\n<strong>M\u00e1jfunkci\u00f3<\/strong> \u2014 alapvizsg\u00e1lat \u00e9s legal\u00e1bb havonta. A rifampicin, izoniazid \u00e9s pirazinamid mind hepatotoxikus; a kombin\u00e1lt kezel\u00e9s klinikailag jelent\u0151s hepatitishez vezet kb. 5%-ban a betegekn\u00e9l. Szak\u00edtsa meg a kezel\u00e9st \u00e9s keressen fel orvost s\u00e1rgas\u00e1g, s\u00f6t\u00e9t vizelet vagy jobb fels\u0151 hasi f\u00e1jdalom eset\u00e9n.<strong>L\u00e1t\u00f3\u00e9less\u00e9g \u00e9s sz\u00ednl\u00e1t\u00e1s<\/strong> \u2014 alapvizsg\u00e1lat \u00e9s havonta etambutol szed\u00e9se alatt. Az etambutolt azonnal sz\u00fcntesse meg b\u00e1rmilyen \u00faj l\u00e1t\u00e1si panasz eset\u00e9n.<strong>L\u00f6kh\u00e1rtya kenet \u00e9s teny\u00e9szt\u00e9s<\/strong> \u2014 a legfontosabb hat\u00e1soss\u00e1gi mutat\u00f3 akt\u00edv t\u00fcd\u0151-TB eset\u00e9n; a negat\u00edv teny\u00e9szt\u00e9sre val\u00f3 \u00e1t\u00e1ll\u00e1s 2 h\u00f3napon bel\u00fcl j\u00f3 v\u00e1laszt jelez.<strong>Vese funkci\u00f3 \u00e9s sz\u00e9rum h\u00fagysav<\/strong> \u2014 az etambutol kiv\u00e1laszt\u00e1sa ves\u00e9n kereszt\u00fcl t\u00f6rt\u00e9nik; a pirazinamid n\u00f6veli a h\u00fagysavszintet \u00e9s k\u00f6szv\u00e9nyt v\u00e1lthat ki.<strong>HIV st\u00e1tusz<\/strong> &mdash; TB-HIV co-infection alters the regimen, the drug interactions, and the prognosis. Every patient with active TB should be offered HIV testing.\nWho this category is not for\nIf you have suspected active TB (chronic cough &gt; 3 weeks, weight loss, night sweats, blood-stained sputum) you need a TB specialist, sputum testing, susceptibility testing, contact tracing, and combination therapy under directly observed treatment &mdash; <strong>nem egyetlen gy\u00f3gyszeres \u00f6nkezel\u00e9sre<\/strong>. A kezeletlen vagy r\u00e9szben kezelt akt\u00edv TB fert\u0151z\u0151, megk\u00f6zel\u00edt\u0151leg a fert\u0151z\u00f6ttek fel\u00e9t meg\u00f6li, \u00e9s az MDR-TB leggyakoribb kiv\u00e1lt\u00f3ja. Ezt az oldalt fel\u00faj\u00edt\u00e1sokra, megl\u00e9v\u0151 fel\u00fcgyelt kezel\u00e9s folytat\u00e1s\u00e1ra, lappang\u00f3 TB-fert\u0151z\u00e9s kezel\u00e9s\u00e9re vagy az egyes term\u00e9koldalakon felsorolt nem TB-s indik\u00e1ci\u00f3kra haszn\u00e1lja.","link":"https:\/\/medsbase.com\/hu\/tuberculosis-treatment\/","name":"Tuberkul\u00f3zis kezel\u00e9se","slug":"tuberculosis-treatment","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat\/4203","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product?product_cat=4203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}